HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

BTSG

BrightSpring Health Services, Inc.

Healthcare — Health Information Services

BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Strong Buy 1.2 / 5 17 analysts
$57.26
+$0.51 (+0.90%)
Target: $76.29 (33.2%)

Price History

52-Week Range
Sign in to add BTSG to a watchlist or set price alerts.

Fundamentals

Market Cap$11.72B
P/E Ratio (TTM)53.31
Forward P/E27.57
EPS (TTM)$1.12
Dividend Yield-
Profit Margin2.27%
Revenue Growth25.60%
ROE9.23%
Debt/Equity135.68
Recommendation Strong Buy 1.2
Analyst Target$76.29
Analysts17
Next Earnings Oct 30, 2026 BMO
Indexes -

Technical Indicators

RSI (14)35.2
Beta1.80
SMA 20$70.13
SMA 40$67.53
52-Week High$73.75
52-Week Low$19.01
50-Day Avg$66.00
200-Day Avg$46.64
Avg Volume$3.87M
Volume$7.69M

Performance Analysis

BULLISH

BTSG shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 70% of its 52-week range.
~ RSI at 35.2 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 53.3 is elevated — the market expects high growth or it may be overvalued.
+ Strong revenue growth of 25.6% year-over-year.
+ Wall Street consensus is "Strong Buy" from 17 analysts.
+ Average analyst target of $76.29 implies 33.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Aug 01, 2026 04:14 UTC

Back to Screener Export Report